RSS   Newsletter   Contact   Advertise with us

Johnson & Johnson to pay $417 million in trial Baby Powder cancer risks

Share on Twitter Share on LinkedIn
Staff Writer |
Baby Powder
Health   The Los Angeles Superior Court

Johnson & Johnson was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

The Los Angeles Superior Court jury's verdict in favor of California resident Eva Echeverria was the largest to date in lawsuits alleging Johnson & Johnson failed to adequately warn consumers about the cancer risks of talc-based products.

The verdict included $70 million in compensatory damages and $347 million in punitive damages, a spokeswoman for Echeverria's lawyers said. It followed several trials in Missouri state court that resulted in more than $300 million in verdicts against Johnson & Johnson.

At trial, lawyers for Echeverria accused the New Jersey-based company of encouraging women to use its talc products despite knowing of years of studies linking ovarian cancer diagnoses and deaths to genital talc use.

Johnson & Johnson's lawyers argued that various scientific studies as well as federal agencies including the U.S. Food and Drug Administration have not found that talc products are carcinogenic.

The trial follows five prior ones in Missouri state court. Johnson & Johnson lost four of those trials and along with a talc supplier has been hit with a total of $307 million in verdicts. Before Monday, the largest verdict was for $110 million.


What to read next
POST Online Media Contact